142 related articles for article (PubMed ID: 10347552)
1. Multiple polysomies in breast carcinomas: preferential gain of chromosomes 1, 5, 6, 7, 12, 16, 17, 18, and 19.
Adeyinka A; Mertens F; Idvall I; Bondeson L; Pandis N
Cancer Genet Cytogenet; 1999 Jun; 111(2):144-8. PubMed ID: 10347552
[TBL] [Abstract][Full Text] [Related]
2. Spectral karyotyping and chromosome banding studies of primary breast carcinomas and their lymph node metastases.
Adeyinka A; Kytola S; Mertens F; Pandis N; Larsson C
Int J Mol Med; 2000 Mar; 5(3):235-40. PubMed ID: 10677562
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic evaluation of 20 primary breast carcinomas.
Cavalli LR; Cavaliéri LM; Ribeiro LA; Cavalli IJ; Silveira R; Rogatto SR
Hereditas; 1997; 126(3):261-8. PubMed ID: 9350140
[TBL] [Abstract][Full Text] [Related]
4. DNA in situ hybridization (interphase cytogenetics) versus comparative genomic hybridization (CGH) in human cancer: detection of numerical and structural chromosome aberrations.
Van Dekken H; Krijtenburg PJ; Alers JC
Acta Histochem; 2000 Feb; 102(1):85-94. PubMed ID: 10726167
[TBL] [Abstract][Full Text] [Related]
5. Instability of chromosomes 1, 3, 16, and 17 in primary breast carcinomas inferred by fluorescence in situ hybridization.
Anamthawat-Jónsson K; Eyfjörd JE; Ogmundsdóttir HM; Pétursdóttir I; Steinarsdóttir M
Cancer Genet Cytogenet; 1996 May; 88(1):1-7. PubMed ID: 8630972
[TBL] [Abstract][Full Text] [Related]
6. Genetic heterogeneity of primary and metastatic breast carcinoma defined by fluorescence in situ hybridization.
Simpson JF; Quan DE; Ho JP; Slovak ML
Am J Pathol; 1996 Sep; 149(3):751-8. PubMed ID: 8780379
[TBL] [Abstract][Full Text] [Related]
7. Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups.
Pandis N; Jin Y; Gorunova L; Petersson C; Bardi G; Idvall I; Johansson B; Ingvar C; Mandahl N; Mitelman F
Genes Chromosomes Cancer; 1995 Mar; 12(3):173-85. PubMed ID: 7536456
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients.
Pandis N; Teixeira MR; Adeyinka A; Rizou H; Bardi G; Mertens F; Andersen JA; Bondeson L; Sfikas K; Qvist H; Apostolikas N; Mitelman F; Heim S
Genes Chromosomes Cancer; 1998 Jun; 22(2):122-9. PubMed ID: 9598799
[TBL] [Abstract][Full Text] [Related]
9. Interstitial deletion of the short arm of chromosome 3 as a primary chromosome abnormality in carcinomas of the breast.
Pandis N; Jin Y; Limon J; Bardi G; Idvall I; Mandahl N; Mitelman F; Heim S
Genes Chromosomes Cancer; 1993 Mar; 6(3):151-5. PubMed ID: 7682099
[TBL] [Abstract][Full Text] [Related]
10. [Interphase cytogenetics of the breast tumors with fluorescence in situ hybridization (FISH) on cytologic preparation--its practice and clinical applications].
Shibuya M; Osamura RY
Nihon Geka Gakkai Zasshi; 1996 May; 97(5):363-7. PubMed ID: 8709938
[TBL] [Abstract][Full Text] [Related]
11. Interphase cytogenetics in oncocytic adenomas and carcinomas of the thyroid gland.
Mazzucchelli L; Burckhardt E; Hirsiger H; Kappeler A; Laissue JA
Hum Pathol; 2000 Jul; 31(7):854-9. PubMed ID: 10923924
[TBL] [Abstract][Full Text] [Related]
12. Numerical aberrations of chromosomes 1 and 7 by fluorescent in situ hybridization and DNA ploidy analysis in breast cancer.
Kapranos N; Kounelis S; Karantasis H; Kouri E
Breast J; 2005; 11(6):448-53. PubMed ID: 16297090
[TBL] [Abstract][Full Text] [Related]
13. Combined cytogenetic and molecular genetic analyses of fifty-nine untreated human prostate carcinomas.
Zitzelsberger H; Szücs S; Robens E; Weier HU; Höfler H; Bauchinger M
Cancer Genet Cytogenet; 1996 Aug; 90(1):37-44. PubMed ID: 8780745
[TBL] [Abstract][Full Text] [Related]
14. Analysis of numerical aberrations of specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer.
Ichikawa D; Hashimoto N; Hoshima M; Yamaguchi T; Sawai K; Nakamura Y; Takahashi T; Abe T; Inazawa J
Cancer; 1996 May; 77(10):2064-9. PubMed ID: 8640671
[TBL] [Abstract][Full Text] [Related]
15. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
[TBL] [Abstract][Full Text] [Related]
16. Interphase cytogenetic studies of human hepatocellular carcinomas by fluorescent in situ hybridization.
Hamon-Benais C; Ingster O; Terris B; Couturier-Turpin MH; Bernheim A; Feldmann G
Hepatology; 1996 Mar; 23(3):429-35. PubMed ID: 8617421
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of breast cancer polyclonality by combined chromosome banding and comparative genomic hybridization analysis.
Teixeira MR; Tsarouha H; Kraggerud SM; Pandis N; Dimitriadis E; Andersen JA; Lothe RA; Heim S
Neoplasia; 2001; 3(3):204-14. PubMed ID: 11494114
[TBL] [Abstract][Full Text] [Related]
18. Molecular cytogenetic analysis of breast cancer: a combined multicolor fluorescence in situ hybridization and G-banding study of uncultured tumor cells.
Ferti AD; Stamouli MJ; Panani AD; Raptis SA; Young BD
Cancer Genet Cytogenet; 2004 Feb; 149(1):28-37. PubMed ID: 15104280
[TBL] [Abstract][Full Text] [Related]
19. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
[TBL] [Abstract][Full Text] [Related]
20. Polysomies but not Y chromosome losses have prognostic significance in pTa/pT1 urinary bladder cancer.
Neuhaus M; Wagner U; Schmid U; Ackermann D; Zellweger T; Maurer R; Alund G; Knönagel H; Rist M; Moch H; Mihatsch MJ; Gasser TC; Sauter G
Hum Pathol; 1999 Jan; 30(1):81-6. PubMed ID: 9923932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
